Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Clover Health Investments ( (CLOV) ) has issued an update.
On June 10, 2025, Clover Health Investments held its Annual Meeting of Stockholders virtually, where three proposals were voted on. The stockholders elected Dr. Anna U. Loengard and William G. Robinson, Jr. as Class I directors, approved the compensation of the Named Executive Officers for 2024, and ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. These decisions reflect the company’s ongoing governance and operational strategies, potentially impacting its future direction and stakeholder confidence.
The most recent analyst rating on (CLOV) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
Clover Health’s stock score is influenced by its ongoing financial challenges, despite positive developments in operational metrics and an encouraging earnings call. The financial performance remains a significant concern due to negative margins and revenue decline. Technical indicators signal potential weakness, while valuation remains unattractive due to losses. The company’s achievements in profitability and membership growth offer potential for future improvement.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Clover Health Investments, Corp. operates in the healthcare industry, focusing on providing Medicare Advantage plans. The company leverages technology to offer a more efficient healthcare experience and aims to improve health outcomes while reducing costs.
Average Trading Volume: 5,676,441
Technical Sentiment Signal: Sell
Current Market Cap: $1.52B
Find detailed analytics on CLOV stock on TipRanks’ Stock Analysis page.